CERo Therapeutics Holdings, Inc. Common Stock Financial Flexibility Index
CERo Therapeutics Holdings, Inc. Common Stock financial flexibility index. CERo Therapeutics Holdings, Inc. Common Stock (CERO) has a Financial Flexibility Index of -0.07x as of June 2026. Free cash flow of $-2.33 Million (operating CF $-2.33 Million minus capex $0.00) represents 0% of total liabilities ($32.41 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of CERo Therapeutics Holdings, Inc. Common Stock (2021–2025)
Financial flexibility index of CERo Therapeutics Holdings, Inc. Common Stock from 2021 to 2025. Historical Financial Flexibility Index trend for CERo Therapeutics Holdings, Inc. Common Stock across 5 annual periods. Check CERO cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CERo Therapeutics Holdings, Inc. Common Stock Financial Flexibility Index by Year (2021–2025)
CERo Therapeutics Holdings, Inc. Common Stock financial flexibility index by year from 2021 to 2025. Year-by-year free cash flow to debt coverage for CERo Therapeutics Holdings, Inc. Common Stock. For the full cash flow conversion analysis, see CERo Therapeutics Holdings, Inc. Common (CERO) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.77x | $-16.08 Million | $-16.08 Million | $9.09 Million | ▼ -147.6% |
| 2024 | -0.71x | $-5.79 Million | $-5.79 Million | $8.10 Million | ▼ -482.4% |
| 2023 | -0.12x | $-5.79 Million | $-5.79 Million | $47.18 Million | ▼ -1130.1% |
| 2022 | -0.01x | $-398.01K | $-1.09 Million | $39.90 Million | ▼ -9.1% |
| 2021 | -0.01x | $-84.54K | $-697.11K | $9.25 Million | — |